Rein advanced the clinical development of its lead asset, LTI-03, and aims to initiate a Phase 2 trial for the treatment of idiopathic pulmonary fibrosis (IPF) in the ...

11,12 Effective step-up treatments in the setting of high-dose ICS+LABA therapy is an unmet need. A recently approved triple-therapy combination — fluticasone furoate, umeclidinium, and vilanterol ...

A new open-source model of brain metabolism—the most complex ever generated—has shown how altering key chemicals could restore aged cells to their youthful activity and resilience. The ...

More information: Roy W. Beck et al, A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes, Diabetes Technology & Therapeutics (2025 ...

The dose ranges for JORNAY PM were much higher than prior stimulant doses, with dose conversion ratios ranging from 1.8 to 6.0 while the adverse event profile for JORNAY PM was consistent with ...

Based on our review of the literature, we propose three approaches to minimizing acute harms: early restriction of cannabis edibles and high-potency products; clear and consistent labelling that ...